Working Time Directive (Limitation) Bill
Official Summary
A Bill to limit the application of the EU Working Time Directive; and for connected purposes.
Summary powered by AnyModel
Overview
This bill aims to limit the scope of the EU Working Time Directive and the UK's implementing regulations. It seeks to exclude certain groups and situations from the rules on maximum working hours, rest periods, and related entitlements.
Description
The Working Time Directive (Limitation) Bill modifies the application of the EU Working Time Directive and the European Working Time Regulations 1998. Key changes include:
- Opt-out: Employees can opt out of the Directive's provisions with their employer's agreement.
- Exemptions: Doctors and other health professionals are exempted. The bill also excludes on-call time (when not actively working), travel time to and from work, time spent working overseas, and considerations of holiday and holiday pay, bonuses, and overtime calculations from the Directive's scope.
Government Spending
The bill's direct impact on government spending is not explicitly stated in the provided text. Indirect effects might include changes in employer costs related to overtime, holiday pay, and potentially litigation related to the changes in the scope of the Directive.
Groups Affected
- Employees: Some employees may experience changes to their working hours, rest periods, and related entitlements depending on their occupation and whether they opt out of the Directive.
- Employers: Employers may face altered costs related to managing working time and potential legal challenges.
- Doctors and health professionals: This group will be exempt from certain provisions of the Directive.
Powered by nyModel
DISCLAIMER: AI technology is not 100% accurate and summaries may contain errors, use at your own risk. Munro Research holds the copyright for all summaries found this website. Reproduction for non-commercial purposes is permitted but must be displayed alongside a link to this website. Contact info@munro-research to license commercially.